FREE DELIVERY ON ALL ORDERS OVER £29*

*Conditions apply - details
Shop by Category
Please enable cookies to use this site. Why?

Free delivery on orders with a VetUK own brand product

Cimalgex

Cimalgex Chewable Tablets are used for the treatment of pain and inflammation and are available in 3 sizes Cimalgex 8mg, Cimalgex 30mg and Cimalgex 80mg. The tablets are oblong, white to pale brown and have an equal break-line on both sides.

Cimalgex Chewable Tablets 8mg

Cimalgex Chewable Tablets 8mg

£0.43

Cimalgex Chewable Tablets are for the treatment of pain and inflammation caused by osteoarthritis in dogs. The tablets are also of great benefit in the management of perioperative pain due...[More info]

£0.43
Cimalgex Chewable Tablets 30mg

Cimalgex Chewable Tablets 30mg

£0.73

Cimalgex Chewable Tablets are for the treatment of pain and inflammation caused by osteoarthritis in dogs. The tablets are also of great benefit in the management of perioperative pain due...[More info]

£0.73
Cimalgex Chewable Tablets 80mg

Cimalgex Chewable Tablets 80mg

£1.12

Cimalgex Chewable Tablets are for the treatment of pain and inflammation caused by osteoarthritis in dogs. The tablets are also of great benefit in the management of perioperative pain due...[More info]

£1.12

Cimicoxib is a non-steroidal anti-inflammatory drug belonging to the coxib group and acting by selective inhibition of the enzyme cyclo-oxygenase 2. The cyclo-oxygenase enzyme (COX) is present in two isoforms. COX-1 is usually a constitutive enzyme expressed in tissues, which synthesize products responsible for normal physiologic functions (e.g. in the gastro-intestinal tract and kidneys). COX-2 on the other hand, is mainly inducible and synthesized by macrophages and inflammatory cells after stimulation by cytokines and other mediators of inflammation. COX-2 is involved in the production of mediators, including PGE2, that induce pain, exudation, inflammation and fever.

In an in vivo inflammatory acute pain model, it was shown that the simulated effect of cimicoxib lasted for approximately 10-14 hours.

After oral administration in dogs at the recommended dose of 2 mg/kg without food, cimicoxib is rapidly absorbed and the time to maximal concentration (Tmax) is 2.25 (± 1.24) hours. The peak concentration (Cmax) is 0.3918 (± 0.09021) µg/ml, area under the curve (AUC) is 1.676 (± 0.4735) µg.hr/ml, and oral bioavailability is 44.53 (± 10.26) percent.

The oral administration of cimicoxib with food did not significantly influence the bioavailability but decreased significantly the observed Tmax.

Metabolism of cimicoxib is extensive. The major metabolite, demethylated cimicoxib is mainly eliminated in faeces by the biliary route and, to a lesser extent, in urine. The other metabolite, glucuronide conjugate of the demethylated cimicoxib, is eliminated in urine. The elimination half-life (t1/2) is 1.38 (± 0.24) hours. The metabolising enzymes have not been fully investigated and slower metabolism (up to four-fold increased exposure) has been noted in some individuals.